Inducibility of lymphokine activated killer (LAK) cells in patients with acute myelogenous leukaemia in complete remission and its clinical relevance.
about
Histamine dihydrochloride and low-dose interleukin-2 as post-consolidation immunotherapy in acute myeloid leukemia.Immunotherapy with histamine dihydrochloride for the prevention of relapse in acute myeloid leukemia.Treatment of minimal residual disease in myeloid leukemia--the immunotherapeutic options with emphasis on Linomide.Influence of malignant cell clonogenic capacities and position along the maturation pathway on their susceptibility to lymphokine-activated killer cell cytotoxicity.Histamine in cancer immunotherapy.Pulsing with blast cell lysate or blast-derived total RNA reverses the dendritic cell-mediated cytotoxic activity of cytokine-induced killer cells against allogeneic acute myelogenous leukemia cells.Intensity of class I antigen expression on human tumour cell lines and its relevance to the efficiency of non-MHC-restricted killingA phase II study of interleukin-2 in 49 patients with relapsed or refractory acute leukemia.Roquinimex (Linomide) vs placebo in AML after autologous bone marrow transplantation
P2860
Q37571981-3B8C3BE5-C987-4700-8C16-CA86E2E011E0Q37810123-A9B5CA4D-320F-4CB1-B4AF-8422FDDAE80CQ40387008-79871FAA-2476-4A61-8DA6-06351827940BQ41056064-CC1478F3-70B8-4369-AC3C-EC39EE7927EBQ41546286-E21B919B-D248-4970-8B4D-9679D3ED4E99Q41844970-CD654983-66DE-4EBB-8F56-5D9D85E3D139Q42389902-24BA5C45-3DB5-472E-A267-0AB85FBA677FQ54110984-472F5049-9651-4640-9143-E4A498C5E6A4Q59194369-3C1111B8-F86C-4482-8B11-4709CBA16747
P2860
Inducibility of lymphokine activated killer (LAK) cells in patients with acute myelogenous leukaemia in complete remission and its clinical relevance.
description
1991 nî lūn-bûn
@nan
1991年の論文
@ja
1991年論文
@yue
1991年論文
@zh-hant
1991年論文
@zh-hk
1991年論文
@zh-mo
1991年論文
@zh-tw
1991年论文
@wuu
1991年论文
@zh
1991年论文
@zh-cn
name
Inducibility of lymphokine act ...... on and its clinical relevance.
@en
type
label
Inducibility of lymphokine act ...... on and its clinical relevance.
@en
prefLabel
Inducibility of lymphokine act ...... on and its clinical relevance.
@en
P2093
P2860
P1476
Inducibility of lymphokine act ...... on and its clinical relevance.
@en
P2093
P2860
P304
P356
10.1111/J.1365-2141.1991.TB08579.X
P407
P577
1991-03-01T00:00:00Z